HHS Drops Plan to Cut Medicare and Medicaid Funding Over Pediatric Gender Care

The Department of Health and Human Services has abandoned a proposed rule that would have stripped Medicare and Medicaid funding from any hospital in the country providing gender-affirming care to minors, according to an official document obtained by NPR.

The rule was proposed in December. HHS took public comment for 60 days, as required, and received more than 30,000 responses, according to NPR. Normally that process ends with a final rule taking effect. Instead, the document shows HHS is walking away from it. It will not be finalized, and it will not take effect within the next year.

Asked about it, the Centers for Medicare and Medicaid Services gave NPR a statement that didn't confirm or deny much: "CMS does not comment on future rulemaking or speculate on potential actions. The Trump Administration rejects ideologically driven surgical interventions on vulnerable children."

That line does considerable work. Surgery on minors for gender dysphoria is rare — NPR notes this explicitly — and the proposed rule wasn't limited to surgery. It covered gender-affirming care broadly, which for minors is overwhelmingly therapy, puberty blockers, and hormones, not operations. CMS's statement frames the fight as being about surgery on kids. The rule itself was not.

Why the rule was unusual

Sam Bagenstos, a Michigan Law professor who served as HHS general counsel under the Biden administration, told NPR the mechanism HHS tried to use here—a Medicare/Medicaid "conditions of participation" rule—has historically been reserved for basic health and safety standards. Think equipment stockpiles, emergency protocols, staffing ratios. Using it to ban a category of medical treatment for a specific population, Bagenstos said, had no real precedent.

He also argued it likely violated the Medicare Act, which bars the federal government from using Medicare and Medicaid to dictate the practice of medicine within a state. States regulate medical practice, not CMS. That's a real legal vulnerability, and it's a plausible reason HHS backed off rather than risk losing in court and setting a bad precedent for future rulemaking.

The American Medical Association and the Children's Hospital Association both filed comments urging HHS to scrap the rule entirely, according to NPR and KPBS. Major U.S. medical groups maintain puberty blockers and hormone treatment are safe and effective for transgender youth. That position represents mainstream clinical consensus. The broader debate over pediatric gender medicine remains genuinely contested among clinicians internationally, with some European health systems, including in England and Sweden, having scaled back or restricted these treatments for minors in recent years over evidence concerns.

The other side of the argument

Supporters of the original rule would say this: parents and taxpayers have a legitimate interest in knowing whether federal health dollars are subsidizing treatments for minors that some medical systems abroad have pulled back on, and using funding conditions to enforce a policy preference isn't unprecedented in federal health law generally, even if this specific application was novel. Bagenstos and the medical associations that filed comments argue the legal vehicle chosen here was flawed and overbroad.

Twenty-seven states already ban gender-affirming care for minors through their own legislation, according to KPBS, meaning the practical effect of the federal rule would have been concentrated in the 23 states plus D.C. where such care remains legal. A national funding cutoff would have applied regardless of state law, effectively using federal money as leverage to override state-level medical policy choices, which is exactly the legal problem Bagenstos flagged.

Not a broader retreat, Bagenstos says

Bagenstos was careful to separate this one decision from the administration's overall posture. "A victory for people who are defending the rights and interests of trans people," he told NPR, but not a signal HHS is stepping back generally. The Trump administration has pursued other measures targeting gender-affirming care, and CMS's own statement doubles down on opposing what it calls "ideologically driven surgical interventions on vulnerable children" rather than conceding any ground on policy direction.

There's no indication HHS is finished pursuing this goal through other channels. The document obtained by NPR only confirms this specific rule won't be finalized in the coming year. Whether HHS attempts a narrower, more legally defensible version, or pursues restrictions through different agencies or executive actions, remains an open question nobody in these reports has answered on the record.